nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—ACHE—Irinotecan—stomach cancer	0.204	0.529	CbGbCtD
Galantamine—BCHE—Irinotecan—stomach cancer	0.123	0.319	CbGbCtD
Galantamine—CYP3A4—Irinotecan—stomach cancer	0.0187	0.0485	CbGbCtD
Galantamine—CYP2D6—Doxorubicin—stomach cancer	0.016	0.0416	CbGbCtD
Galantamine—BCHE—diaphragm—stomach cancer	0.0149	0.14	CbGeAlD
Galantamine—CYP3A4—Docetaxel—stomach cancer	0.0137	0.0355	CbGbCtD
Galantamine—CYP3A4—Doxorubicin—stomach cancer	0.0102	0.0265	CbGbCtD
Galantamine—CHRNA10—hematopoietic system—stomach cancer	0.00607	0.0568	CbGeAlD
Galantamine—CHRNA1—hematopoietic system—stomach cancer	0.00474	0.0443	CbGeAlD
Galantamine—CHRNG—bone marrow—stomach cancer	0.00459	0.0429	CbGeAlD
Galantamine—CHRNA10—lymphoid tissue—stomach cancer	0.00427	0.04	CbGeAlD
Galantamine—CHRNA3—hematopoietic system—stomach cancer	0.00423	0.0396	CbGeAlD
Galantamine—CHRNA5—lymph node—stomach cancer	0.00398	0.0372	CbGeAlD
Galantamine—CHRNB2—smooth muscle tissue—stomach cancer	0.00384	0.0359	CbGeAlD
Galantamine—CHRFAM7A—hematopoietic system—stomach cancer	0.00342	0.032	CbGeAlD
Galantamine—CHRNA1—lymphoid tissue—stomach cancer	0.00333	0.0312	CbGeAlD
Galantamine—CHRNA3—lymphoid tissue—stomach cancer	0.00298	0.0279	CbGeAlD
Galantamine—CHRNB2—bone marrow—stomach cancer	0.00279	0.0262	CbGeAlD
Galantamine—CHRNA7—hematopoietic system—stomach cancer	0.00276	0.0259	CbGeAlD
Galantamine—CHRNA4—hematopoietic system—stomach cancer	0.00272	0.0255	CbGeAlD
Galantamine—CHRNA1—endocrine gland—stomach cancer	0.00272	0.0255	CbGeAlD
Galantamine—CHRNA3—endocrine gland—stomach cancer	0.00243	0.0227	CbGeAlD
Galantamine—CHRNA10—lymph node—stomach cancer	0.00241	0.0226	CbGeAlD
Galantamine—CHRNA2—endocrine gland—stomach cancer	0.00226	0.0211	CbGeAlD
Galantamine—CHRNB2—liver—stomach cancer	0.00226	0.0211	CbGeAlD
Galantamine—CHRFAM7A—endocrine gland—stomach cancer	0.00196	0.0184	CbGeAlD
Galantamine—CHRNA7—digestive system—stomach cancer	0.00192	0.018	CbGeAlD
Galantamine—CHRNB1—liver—stomach cancer	0.00189	0.0177	CbGeAlD
Galantamine—CHRNA4—digestive system—stomach cancer	0.00189	0.0177	CbGeAlD
Galantamine—CHRNB2—lymph node—stomach cancer	0.00173	0.0162	CbGeAlD
Galantamine—CHRNA3—lymph node—stomach cancer	0.00168	0.0157	CbGeAlD
Galantamine—CHRNA7—endocrine gland—stomach cancer	0.00159	0.0149	CbGeAlD
Galantamine—CHRNA4—endocrine gland—stomach cancer	0.00157	0.0147	CbGeAlD
Galantamine—BCHE—hematopoietic system—stomach cancer	0.00156	0.0146	CbGeAlD
Galantamine—CHRNB1—lymph node—stomach cancer	0.00145	0.0136	CbGeAlD
Galantamine—BCHE—smooth muscle tissue—stomach cancer	0.00137	0.0129	CbGeAlD
Galantamine—ACHE—lymph node—stomach cancer	0.00126	0.0118	CbGeAlD
Galantamine—BCHE—digestive system—stomach cancer	0.00108	0.0101	CbGeAlD
Galantamine—CYP3A4—hematopoietic system—stomach cancer	0.00105	0.00982	CbGeAlD
Galantamine—CYP2D6—hematopoietic system—stomach cancer	0.00103	0.00967	CbGeAlD
Galantamine—BCHE—bone marrow—stomach cancer	0.000999	0.00935	CbGeAlD
Galantamine—BCHE—endocrine gland—stomach cancer	0.000896	0.00838	CbGeAlD
Galantamine—BCHE—liver—stomach cancer	0.000807	0.00756	CbGeAlD
Galantamine—CYP3A4—digestive system—stomach cancer	0.00073	0.00683	CbGeAlD
Galantamine—CYP2D6—digestive system—stomach cancer	0.000718	0.00672	CbGeAlD
Galantamine—BCHE—lymph node—stomach cancer	0.000619	0.0058	CbGeAlD
Galantamine—CYP3A4—endocrine gland—stomach cancer	0.000603	0.00565	CbGeAlD
Galantamine—CYP2D6—endocrine gland—stomach cancer	0.000593	0.00556	CbGeAlD
Galantamine—CYP3A4—liver—stomach cancer	0.000544	0.00509	CbGeAlD
Galantamine—CYP2D6—liver—stomach cancer	0.000535	0.00501	CbGeAlD
Galantamine—Oedema peripheral—Epirubicin—stomach cancer	0.000336	0.000854	CcSEcCtD
Galantamine—Hypotension—Docetaxel—stomach cancer	0.000336	0.000853	CcSEcCtD
Galantamine—Haematuria—Doxorubicin—stomach cancer	0.000335	0.000851	CcSEcCtD
Galantamine—Connective tissue disorder—Epirubicin—stomach cancer	0.000335	0.000851	CcSEcCtD
Galantamine—Urethral disorder—Epirubicin—stomach cancer	0.000334	0.000849	CcSEcCtD
Galantamine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000332	0.000845	CcSEcCtD
Galantamine—Epistaxis—Doxorubicin—stomach cancer	0.000331	0.000842	CcSEcCtD
Galantamine—Anorexia—Capecitabine—stomach cancer	0.000331	0.000842	CcSEcCtD
Galantamine—Angiopathy—Methotrexate—stomach cancer	0.00033	0.00084	CcSEcCtD
Galantamine—Vomiting—Irinotecan—stomach cancer	0.00033	0.000839	CcSEcCtD
Galantamine—Immune system disorder—Methotrexate—stomach cancer	0.000329	0.000836	CcSEcCtD
Galantamine—Dizziness—Fluorouracil—stomach cancer	0.000329	0.000836	CcSEcCtD
Galantamine—Visual impairment—Epirubicin—stomach cancer	0.000329	0.000835	CcSEcCtD
Galantamine—Rash—Irinotecan—stomach cancer	0.000327	0.000832	CcSEcCtD
Galantamine—Dermatitis—Irinotecan—stomach cancer	0.000327	0.000832	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000327	0.000831	CcSEcCtD
Galantamine—Headache—Irinotecan—stomach cancer	0.000325	0.000827	CcSEcCtD
Galantamine—Hypotension—Capecitabine—stomach cancer	0.000325	0.000826	CcSEcCtD
Galantamine—Insomnia—Docetaxel—stomach cancer	0.000325	0.000825	CcSEcCtD
Galantamine—Paraesthesia—Docetaxel—stomach cancer	0.000322	0.000819	CcSEcCtD
Galantamine—Bradycardia—Doxorubicin—stomach cancer	0.000321	0.000816	CcSEcCtD
Galantamine—Somnolence—Docetaxel—stomach cancer	0.000319	0.000811	CcSEcCtD
Galantamine—Mental disorder—Methotrexate—stomach cancer	0.000319	0.000811	CcSEcCtD
Galantamine—Eye disorder—Epirubicin—stomach cancer	0.000319	0.00081	CcSEcCtD
Galantamine—Tinnitus—Epirubicin—stomach cancer	0.000318	0.000808	CcSEcCtD
Galantamine—Malnutrition—Methotrexate—stomach cancer	0.000317	0.000806	CcSEcCtD
Galantamine—Haemoglobin—Doxorubicin—stomach cancer	0.000317	0.000806	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000317	0.000805	CcSEcCtD
Galantamine—Flushing—Epirubicin—stomach cancer	0.000316	0.000804	CcSEcCtD
Galantamine—Cardiac disorder—Epirubicin—stomach cancer	0.000316	0.000804	CcSEcCtD
Galantamine—Vomiting—Fluorouracil—stomach cancer	0.000316	0.000804	CcSEcCtD
Galantamine—Rhinitis—Doxorubicin—stomach cancer	0.000316	0.000804	CcSEcCtD
Galantamine—Dyspepsia—Docetaxel—stomach cancer	0.000316	0.000803	CcSEcCtD
Galantamine—Haemorrhage—Doxorubicin—stomach cancer	0.000315	0.000802	CcSEcCtD
Galantamine—Hepatitis—Doxorubicin—stomach cancer	0.000315	0.000802	CcSEcCtD
Galantamine—Insomnia—Capecitabine—stomach cancer	0.000314	0.000799	CcSEcCtD
Galantamine—Rash—Fluorouracil—stomach cancer	0.000314	0.000797	CcSEcCtD
Galantamine—Dermatitis—Fluorouracil—stomach cancer	0.000313	0.000797	CcSEcCtD
Galantamine—Paraesthesia—Capecitabine—stomach cancer	0.000312	0.000793	CcSEcCtD
Galantamine—Decreased appetite—Docetaxel—stomach cancer	0.000312	0.000793	CcSEcCtD
Galantamine—Headache—Fluorouracil—stomach cancer	0.000312	0.000792	CcSEcCtD
Galantamine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000311	0.000792	CcSEcCtD
Galantamine—Oedema peripheral—Doxorubicin—stomach cancer	0.000311	0.00079	CcSEcCtD
Galantamine—Dysgeusia—Methotrexate—stomach cancer	0.000311	0.000789	CcSEcCtD
Galantamine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00031	0.000788	CcSEcCtD
Galantamine—Connective tissue disorder—Doxorubicin—stomach cancer	0.00031	0.000788	CcSEcCtD
Galantamine—Fatigue—Docetaxel—stomach cancer	0.00031	0.000787	CcSEcCtD
Galantamine—Angiopathy—Epirubicin—stomach cancer	0.000309	0.000786	CcSEcCtD
Galantamine—Urethral disorder—Doxorubicin—stomach cancer	0.000309	0.000786	CcSEcCtD
Galantamine—Nausea—Irinotecan—stomach cancer	0.000309	0.000784	CcSEcCtD
Galantamine—Immune system disorder—Epirubicin—stomach cancer	0.000308	0.000783	CcSEcCtD
Galantamine—Constipation—Docetaxel—stomach cancer	0.000307	0.00078	CcSEcCtD
Galantamine—Back pain—Methotrexate—stomach cancer	0.000307	0.00078	CcSEcCtD
Galantamine—Dyspepsia—Capecitabine—stomach cancer	0.000306	0.000778	CcSEcCtD
Galantamine—Arrhythmia—Epirubicin—stomach cancer	0.000305	0.000774	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—stomach cancer	0.000304	0.000773	CcSEcCtD
Galantamine—Decreased appetite—Capecitabine—stomach cancer	0.000302	0.000768	CcSEcCtD
Galantamine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.0003	0.000763	CcSEcCtD
Galantamine—Fatigue—Capecitabine—stomach cancer	0.0003	0.000762	CcSEcCtD
Galantamine—Vision blurred—Methotrexate—stomach cancer	0.000299	0.00076	CcSEcCtD
Galantamine—Mental disorder—Epirubicin—stomach cancer	0.000299	0.000759	CcSEcCtD
Galantamine—Constipation—Capecitabine—stomach cancer	0.000297	0.000756	CcSEcCtD
Galantamine—Malnutrition—Epirubicin—stomach cancer	0.000297	0.000754	CcSEcCtD
Galantamine—Feeling abnormal—Docetaxel—stomach cancer	0.000296	0.000752	CcSEcCtD
Galantamine—Nausea—Fluorouracil—stomach cancer	0.000295	0.000751	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—stomach cancer	0.000295	0.000749	CcSEcCtD
Galantamine—Ill-defined disorder—Methotrexate—stomach cancer	0.000294	0.000748	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—stomach cancer	0.000294	0.000747	CcSEcCtD
Galantamine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000294	0.000746	CcSEcCtD
Galantamine—Anaemia—Methotrexate—stomach cancer	0.000293	0.000745	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—stomach cancer	0.000293	0.000744	CcSEcCtD
Galantamine—Flushing—Doxorubicin—stomach cancer	0.000293	0.000744	CcSEcCtD
Galantamine—Flatulence—Epirubicin—stomach cancer	0.000292	0.000743	CcSEcCtD
Galantamine—Tension—Epirubicin—stomach cancer	0.000291	0.00074	CcSEcCtD
Galantamine—Dysgeusia—Epirubicin—stomach cancer	0.000291	0.000739	CcSEcCtD
Galantamine—Nervousness—Epirubicin—stomach cancer	0.000288	0.000733	CcSEcCtD
Galantamine—Back pain—Epirubicin—stomach cancer	0.000287	0.00073	CcSEcCtD
Galantamine—Feeling abnormal—Capecitabine—stomach cancer	0.000286	0.000728	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—stomach cancer	0.000286	0.000727	CcSEcCtD
Galantamine—Malaise—Methotrexate—stomach cancer	0.000286	0.000727	CcSEcCtD
Galantamine—Muscle spasms—Epirubicin—stomach cancer	0.000285	0.000725	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—stomach cancer	0.000285	0.000724	CcSEcCtD
Galantamine—Vertigo—Methotrexate—stomach cancer	0.000285	0.000724	CcSEcCtD
Galantamine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000284	0.000723	CcSEcCtD
Galantamine—Body temperature increased—Docetaxel—stomach cancer	0.000284	0.000721	CcSEcCtD
Galantamine—Abdominal pain—Docetaxel—stomach cancer	0.000284	0.000721	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—stomach cancer	0.000282	0.000716	CcSEcCtD
Galantamine—Vision blurred—Epirubicin—stomach cancer	0.00028	0.000711	CcSEcCtD
Galantamine—Cough—Methotrexate—stomach cancer	0.000277	0.000703	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—stomach cancer	0.000276	0.000702	CcSEcCtD
Galantamine—Ill-defined disorder—Epirubicin—stomach cancer	0.000275	0.0007	CcSEcCtD
Galantamine—Abdominal pain—Capecitabine—stomach cancer	0.000275	0.000698	CcSEcCtD
Galantamine—Body temperature increased—Capecitabine—stomach cancer	0.000275	0.000698	CcSEcCtD
Galantamine—Convulsion—Methotrexate—stomach cancer	0.000275	0.000698	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—stomach cancer	0.000275	0.000698	CcSEcCtD
Galantamine—Anaemia—Epirubicin—stomach cancer	0.000274	0.000697	CcSEcCtD
Galantamine—Agitation—Epirubicin—stomach cancer	0.000273	0.000693	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—stomach cancer	0.000271	0.000688	CcSEcCtD
Galantamine—Chest pain—Methotrexate—stomach cancer	0.00027	0.000686	CcSEcCtD
Galantamine—Myalgia—Methotrexate—stomach cancer	0.00027	0.000686	CcSEcCtD
Galantamine—Arthralgia—Methotrexate—stomach cancer	0.00027	0.000686	CcSEcCtD
Galantamine—Tension—Doxorubicin—stomach cancer	0.000269	0.000685	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—stomach cancer	0.000269	0.000683	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000268	0.000681	CcSEcCtD
Galantamine—Malaise—Epirubicin—stomach cancer	0.000268	0.00068	CcSEcCtD
Galantamine—Discomfort—Methotrexate—stomach cancer	0.000267	0.000678	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—stomach cancer	0.000267	0.000678	CcSEcCtD
Galantamine—Vertigo—Epirubicin—stomach cancer	0.000267	0.000678	CcSEcCtD
Galantamine—Syncope—Epirubicin—stomach cancer	0.000266	0.000676	CcSEcCtD
Galantamine—Back pain—Doxorubicin—stomach cancer	0.000266	0.000675	CcSEcCtD
Galantamine—Hypersensitivity—Docetaxel—stomach cancer	0.000265	0.000672	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—stomach cancer	0.000264	0.000671	CcSEcCtD
Galantamine—Palpitations—Epirubicin—stomach cancer	0.000262	0.000667	CcSEcCtD
Galantamine—Confusional state—Methotrexate—stomach cancer	0.000261	0.000663	CcSEcCtD
Galantamine—Loss of consciousness—Epirubicin—stomach cancer	0.000261	0.000663	CcSEcCtD
Galantamine—Cough—Epirubicin—stomach cancer	0.000259	0.000658	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—stomach cancer	0.000259	0.000658	CcSEcCtD
Galantamine—Asthenia—Docetaxel—stomach cancer	0.000258	0.000655	CcSEcCtD
Galantamine—Convulsion—Epirubicin—stomach cancer	0.000257	0.000653	CcSEcCtD
Galantamine—Hypertension—Epirubicin—stomach cancer	0.000256	0.000651	CcSEcCtD
Galantamine—Hypersensitivity—Capecitabine—stomach cancer	0.000256	0.000651	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000255	0.000648	CcSEcCtD
Galantamine—Nervous system disorder—Methotrexate—stomach cancer	0.000254	0.000645	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—stomach cancer	0.000254	0.000645	CcSEcCtD
Galantamine—Thrombocytopenia—Methotrexate—stomach cancer	0.000253	0.000644	CcSEcCtD
Galantamine—Arthralgia—Epirubicin—stomach cancer	0.000253	0.000642	CcSEcCtD
Galantamine—Chest pain—Epirubicin—stomach cancer	0.000253	0.000642	CcSEcCtD
Galantamine—Myalgia—Epirubicin—stomach cancer	0.000253	0.000642	CcSEcCtD
Galantamine—Agitation—Doxorubicin—stomach cancer	0.000252	0.000641	CcSEcCtD
Galantamine—Anxiety—Epirubicin—stomach cancer	0.000252	0.00064	CcSEcCtD
Galantamine—Skin disorder—Methotrexate—stomach cancer	0.000251	0.000639	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000251	0.000638	CcSEcCtD
Galantamine—Hyperhidrosis—Methotrexate—stomach cancer	0.00025	0.000636	CcSEcCtD
Galantamine—Discomfort—Epirubicin—stomach cancer	0.00025	0.000634	CcSEcCtD
Galantamine—Asthenia—Capecitabine—stomach cancer	0.000249	0.000634	CcSEcCtD
Galantamine—Malaise—Doxorubicin—stomach cancer	0.000248	0.000629	CcSEcCtD
Galantamine—Dry mouth—Epirubicin—stomach cancer	0.000247	0.000628	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—stomach cancer	0.000247	0.000627	CcSEcCtD
Galantamine—Anorexia—Methotrexate—stomach cancer	0.000247	0.000627	CcSEcCtD
Galantamine—Syncope—Doxorubicin—stomach cancer	0.000246	0.000626	CcSEcCtD
Galantamine—Diarrhoea—Docetaxel—stomach cancer	0.000246	0.000624	CcSEcCtD
Galantamine—Confusional state—Epirubicin—stomach cancer	0.000244	0.000621	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—stomach cancer	0.000243	0.000617	CcSEcCtD
Galantamine—Hypotension—Methotrexate—stomach cancer	0.000242	0.000615	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—stomach cancer	0.000241	0.000613	CcSEcCtD
Galantamine—Cough—Doxorubicin—stomach cancer	0.00024	0.000609	CcSEcCtD
Galantamine—Shock—Epirubicin—stomach cancer	0.000238	0.000606	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—stomach cancer	0.000238	0.000605	CcSEcCtD
Galantamine—Diarrhoea—Capecitabine—stomach cancer	0.000238	0.000605	CcSEcCtD
Galantamine—Nervous system disorder—Epirubicin—stomach cancer	0.000238	0.000604	CcSEcCtD
Galantamine—Dizziness—Docetaxel—stomach cancer	0.000237	0.000603	CcSEcCtD
Galantamine—Thrombocytopenia—Epirubicin—stomach cancer	0.000237	0.000603	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—stomach cancer	0.000237	0.000603	CcSEcCtD
Galantamine—Tachycardia—Epirubicin—stomach cancer	0.000236	0.000601	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000236	0.000599	CcSEcCtD
Galantamine—Skin disorder—Epirubicin—stomach cancer	0.000235	0.000598	CcSEcCtD
Galantamine—Hyperhidrosis—Epirubicin—stomach cancer	0.000234	0.000595	CcSEcCtD
Galantamine—Insomnia—Methotrexate—stomach cancer	0.000234	0.000595	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—stomach cancer	0.000234	0.000594	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—stomach cancer	0.000234	0.000594	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—stomach cancer	0.000234	0.000594	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—stomach cancer	0.000233	0.000592	CcSEcCtD
Galantamine—Paraesthesia—Methotrexate—stomach cancer	0.000232	0.000591	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000232	0.00059	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—stomach cancer	0.000231	0.000587	CcSEcCtD
Galantamine—Anorexia—Epirubicin—stomach cancer	0.000231	0.000587	CcSEcCtD
Galantamine—Somnolence—Methotrexate—stomach cancer	0.00023	0.000585	CcSEcCtD
Galantamine—Dizziness—Capecitabine—stomach cancer	0.00023	0.000584	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—stomach cancer	0.000229	0.000581	CcSEcCtD
Galantamine—Vomiting—Docetaxel—stomach cancer	0.000228	0.00058	CcSEcCtD
Galantamine—Dyspepsia—Methotrexate—stomach cancer	0.000228	0.000579	CcSEcCtD
Galantamine—Rash—Docetaxel—stomach cancer	0.000226	0.000575	CcSEcCtD
Galantamine—Hypotension—Epirubicin—stomach cancer	0.000226	0.000575	CcSEcCtD
Galantamine—Dermatitis—Docetaxel—stomach cancer	0.000226	0.000575	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—stomach cancer	0.000226	0.000574	CcSEcCtD
Galantamine—Decreased appetite—Methotrexate—stomach cancer	0.000225	0.000572	CcSEcCtD
Galantamine—Headache—Docetaxel—stomach cancer	0.000225	0.000572	CcSEcCtD
Galantamine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000223	0.000568	CcSEcCtD
Galantamine—Fatigue—Methotrexate—stomach cancer	0.000223	0.000567	CcSEcCtD
Galantamine—Vomiting—Capecitabine—stomach cancer	0.000221	0.000562	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000221	0.000561	CcSEcCtD
Galantamine—Shock—Doxorubicin—stomach cancer	0.00022	0.00056	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—stomach cancer	0.00022	0.000559	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000219	0.000558	CcSEcCtD
Galantamine—Rash—Capecitabine—stomach cancer	0.000219	0.000557	CcSEcCtD
Galantamine—Insomnia—Epirubicin—stomach cancer	0.000219	0.000557	CcSEcCtD
Galantamine—Dermatitis—Capecitabine—stomach cancer	0.000219	0.000557	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—stomach cancer	0.000219	0.000556	CcSEcCtD
Galantamine—Headache—Capecitabine—stomach cancer	0.000218	0.000554	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—stomach cancer	0.000218	0.000553	CcSEcCtD
Galantamine—Paraesthesia—Epirubicin—stomach cancer	0.000217	0.000553	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000217	0.000551	CcSEcCtD
Galantamine—Somnolence—Epirubicin—stomach cancer	0.000215	0.000547	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—stomach cancer	0.000214	0.000543	CcSEcCtD
Galantamine—Nausea—Docetaxel—stomach cancer	0.000213	0.000542	CcSEcCtD
Galantamine—Feeling abnormal—Methotrexate—stomach cancer	0.000213	0.000542	CcSEcCtD
Galantamine—Dyspepsia—Epirubicin—stomach cancer	0.000213	0.000542	CcSEcCtD
Galantamine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000212	0.000538	CcSEcCtD
Galantamine—Decreased appetite—Epirubicin—stomach cancer	0.000211	0.000535	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—stomach cancer	0.000209	0.000532	CcSEcCtD
Galantamine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000209	0.000531	CcSEcCtD
Galantamine—Fatigue—Epirubicin—stomach cancer	0.000209	0.000531	CcSEcCtD
Galantamine—Constipation—Epirubicin—stomach cancer	0.000207	0.000526	CcSEcCtD
Galantamine—Nausea—Capecitabine—stomach cancer	0.000206	0.000525	CcSEcCtD
Galantamine—Body temperature increased—Methotrexate—stomach cancer	0.000205	0.00052	CcSEcCtD
Galantamine—Abdominal pain—Methotrexate—stomach cancer	0.000205	0.00052	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000204	0.000519	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—stomach cancer	0.000203	0.000515	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—stomach cancer	0.000201	0.000511	CcSEcCtD
Galantamine—Feeling abnormal—Epirubicin—stomach cancer	0.0002	0.000507	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—stomach cancer	0.000199	0.000506	CcSEcCtD
Galantamine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000198	0.000503	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—stomach cancer	0.000197	0.000501	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—stomach cancer	0.000195	0.000495	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000193	0.000492	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—stomach cancer	0.000193	0.000491	CcSEcCtD
Galantamine—Constipation—Doxorubicin—stomach cancer	0.000192	0.000487	CcSEcCtD
Galantamine—Body temperature increased—Epirubicin—stomach cancer	0.000191	0.000487	CcSEcCtD
Galantamine—Abdominal pain—Epirubicin—stomach cancer	0.000191	0.000487	CcSEcCtD
Galantamine—Hypersensitivity—Methotrexate—stomach cancer	0.000191	0.000485	CcSEcCtD
Galantamine—Asthenia—Methotrexate—stomach cancer	0.000186	0.000472	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—stomach cancer	0.000185	0.000469	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000183	0.000466	CcSEcCtD
Galantamine—Hypersensitivity—Epirubicin—stomach cancer	0.000178	0.000454	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—stomach cancer	0.000177	0.00045	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—stomach cancer	0.000177	0.00045	CcSEcCtD
Galantamine—Diarrhoea—Methotrexate—stomach cancer	0.000177	0.00045	CcSEcCtD
Galantamine—Asthenia—Epirubicin—stomach cancer	0.000174	0.000442	CcSEcCtD
Galantamine—Dizziness—Methotrexate—stomach cancer	0.000171	0.000435	CcSEcCtD
Galantamine—Diarrhoea—Epirubicin—stomach cancer	0.000166	0.000421	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—stomach cancer	0.000165	0.00042	CcSEcCtD
Galantamine—Vomiting—Methotrexate—stomach cancer	0.000165	0.000418	CcSEcCtD
Galantamine—Rash—Methotrexate—stomach cancer	0.000163	0.000415	CcSEcCtD
Galantamine—Dermatitis—Methotrexate—stomach cancer	0.000163	0.000414	CcSEcCtD
Galantamine—Headache—Methotrexate—stomach cancer	0.000162	0.000412	CcSEcCtD
Galantamine—Asthenia—Doxorubicin—stomach cancer	0.000161	0.000409	CcSEcCtD
Galantamine—Dizziness—Epirubicin—stomach cancer	0.00016	0.000407	CcSEcCtD
Galantamine—Vomiting—Epirubicin—stomach cancer	0.000154	0.000391	CcSEcCtD
Galantamine—Nausea—Methotrexate—stomach cancer	0.000154	0.000391	CcSEcCtD
Galantamine—Diarrhoea—Doxorubicin—stomach cancer	0.000153	0.00039	CcSEcCtD
Galantamine—Rash—Epirubicin—stomach cancer	0.000153	0.000388	CcSEcCtD
Galantamine—Dermatitis—Epirubicin—stomach cancer	0.000153	0.000388	CcSEcCtD
Galantamine—Headache—Epirubicin—stomach cancer	0.000152	0.000386	CcSEcCtD
Galantamine—Dizziness—Doxorubicin—stomach cancer	0.000148	0.000377	CcSEcCtD
Galantamine—Nausea—Epirubicin—stomach cancer	0.000144	0.000366	CcSEcCtD
Galantamine—Vomiting—Doxorubicin—stomach cancer	0.000142	0.000362	CcSEcCtD
Galantamine—Rash—Doxorubicin—stomach cancer	0.000141	0.000359	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—stomach cancer	0.000141	0.000359	CcSEcCtD
Galantamine—Headache—Doxorubicin—stomach cancer	0.00014	0.000357	CcSEcCtD
Galantamine—Nausea—Doxorubicin—stomach cancer	0.000133	0.000338	CcSEcCtD
Galantamine—CHRNA3—Transmission across Chemical Synapses—HRAS—stomach cancer	6.65e-05	0.000581	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLIN2—stomach cancer	6.52e-05	0.00057	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—RPS19—stomach cancer	6.46e-05	0.000565	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—MAPK1—stomach cancer	6.41e-05	0.00056	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PAX6—stomach cancer	6.39e-05	0.000559	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—MAPK1—stomach cancer	6.35e-05	0.000555	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CA2—stomach cancer	6.34e-05	0.000554	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	6.33e-05	0.000554	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—HRAS—stomach cancer	6.31e-05	0.000552	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—HRAS—stomach cancer	6.24e-05	0.000546	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA1—stomach cancer	6.18e-05	0.000541	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CKB—stomach cancer	6.18e-05	0.000541	CbGpPWpGaD
Galantamine—BCHE—Metabolism—FBP1—stomach cancer	6.18e-05	0.000541	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NDUFA2—stomach cancer	6.18e-05	0.000541	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NT5E—stomach cancer	6.18e-05	0.00054	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PGAM1—stomach cancer	6.18e-05	0.00054	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGFBP3—stomach cancer	6.14e-05	0.000537	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—PRKCB—stomach cancer	6.06e-05	0.00053	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	6.04e-05	0.000528	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	6.03e-05	0.000527	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—MAPK1—stomach cancer	6.02e-05	0.000526	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—stomach cancer	6.01e-05	0.000525	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—MAPK1—stomach cancer	5.96e-05	0.000521	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—HRAS—stomach cancer	5.93e-05	0.000519	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALDH7A1—stomach cancer	5.89e-05	0.000515	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLCE1—stomach cancer	5.89e-05	0.000515	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.85e-05	0.000511	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLIN2—stomach cancer	5.81e-05	0.000508	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—RPS19—stomach cancer	5.77e-05	0.000504	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTP1—stomach cancer	5.76e-05	0.000503	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—RPS6—stomach cancer	5.71e-05	0.0005	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.71e-05	0.000499	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PAX6—stomach cancer	5.7e-05	0.000499	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTP1—stomach cancer	5.68e-05	0.000497	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACE—stomach cancer	5.67e-05	0.000496	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—MAPK1—stomach cancer	5.66e-05	0.000495	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA2—stomach cancer	5.66e-05	0.000494	CbGpPWpGaD
Galantamine—ACHE—Metabolism—UMPS—stomach cancer	5.65e-05	0.000494	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—HRAS—stomach cancer	5.63e-05	0.000492	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—HRAS—stomach cancer	5.57e-05	0.000487	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NT5E—stomach cancer	5.51e-05	0.000482	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PGAM1—stomach cancer	5.51e-05	0.000482	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTT1—stomach cancer	5.43e-05	0.000475	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	5.37e-05	0.000469	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CA—stomach cancer	5.34e-05	0.000467	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTM1—stomach cancer	5.29e-05	0.000463	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	5.27e-05	0.000461	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDH7A1—stomach cancer	5.26e-05	0.00046	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLCE1—stomach cancer	5.26e-05	0.00046	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PDHA1—stomach cancer	5.25e-05	0.000459	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ECHS1—stomach cancer	5.25e-05	0.000459	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—stomach cancer	5.22e-05	0.000456	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	5.15e-05	0.00045	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—HRAS—stomach cancer	5.14e-05	0.00045	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—RPS6—stomach cancer	5.1e-05	0.000446	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—HRAS—stomach cancer	5.09e-05	0.000445	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACE—stomach cancer	5.06e-05	0.000442	CbGpPWpGaD
Galantamine—BCHE—Metabolism—UMPS—stomach cancer	5.04e-05	0.000441	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.98e-05	0.000436	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACAD8—stomach cancer	4.95e-05	0.000433	CbGpPWpGaD
Galantamine—ACHE—Metabolism—FADS1—stomach cancer	4.94e-05	0.000432	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TYMP—stomach cancer	4.94e-05	0.000432	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—MAPK1—stomach cancer	4.91e-05	0.000429	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.85e-05	0.000424	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—HRAS—stomach cancer	4.83e-05	0.000423	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—HRAS—stomach cancer	4.78e-05	0.000418	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CA—stomach cancer	4.76e-05	0.000416	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.74e-05	0.000415	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.74e-05	0.000414	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PDHA1—stomach cancer	4.69e-05	0.00041	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ECHS1—stomach cancer	4.69e-05	0.00041	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SREBF2—stomach cancer	4.63e-05	0.000404	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—MAPK1—stomach cancer	4.57e-05	0.0004	CbGpPWpGaD
Galantamine—ACHE—Metabolism—RORA—stomach cancer	4.57e-05	0.0004	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—HRAS—stomach cancer	4.55e-05	0.000397	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.52e-05	0.000395	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.48e-05	0.000392	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GMPR2—stomach cancer	4.41e-05	0.000386	CbGpPWpGaD
Galantamine—BCHE—Metabolism—FADS1—stomach cancer	4.41e-05	0.000385	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TYMP—stomach cancer	4.41e-05	0.000385	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALDOB—stomach cancer	4.28e-05	0.000374	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SREBF2—stomach cancer	4.13e-05	0.000361	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	4.11e-05	0.00036	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—MAPK1—stomach cancer	4.08e-05	0.000356	CbGpPWpGaD
Galantamine—BCHE—Metabolism—RORA—stomach cancer	4.08e-05	0.000356	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.04e-05	0.000353	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—IDH3B—stomach cancer	4.04e-05	0.000353	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SUCLG1—stomach cancer	4.04e-05	0.000353	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.03e-05	0.000352	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALOX5—stomach cancer	3.98e-05	0.000348	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.98e-05	0.000348	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—HRAS—stomach cancer	3.94e-05	0.000345	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DPYD—stomach cancer	3.92e-05	0.000342	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDOB—stomach cancer	3.82e-05	0.000334	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—stomach cancer	3.76e-05	0.000329	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NDUFV1—stomach cancer	3.75e-05	0.000328	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NDUFS1—stomach cancer	3.75e-05	0.000328	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	3.71e-05	0.000325	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—HRAS—stomach cancer	3.67e-05	0.000321	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.6e-05	0.000315	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.59e-05	0.000314	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALOX5—stomach cancer	3.55e-05	0.000311	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.55e-05	0.00031	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MAPK1—stomach cancer	3.5e-05	0.000306	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DPYD—stomach cancer	3.49e-05	0.000305	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTT1—stomach cancer	3.46e-05	0.000303	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—stomach cancer	3.46e-05	0.000302	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2A6—stomach cancer	3.42e-05	0.000299	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	3.41e-05	0.000298	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BLVRB—stomach cancer	3.34e-05	0.000292	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PGLS—stomach cancer	3.34e-05	0.000292	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKR1C3—stomach cancer	3.33e-05	0.000291	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—HRAS—stomach cancer	3.27e-05	0.000286	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ENO1—stomach cancer	3.25e-05	0.000284	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACAD8—stomach cancer	3.24e-05	0.000283	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.19e-05	0.000279	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPAP2A—stomach cancer	3.19e-05	0.000279	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.17e-05	0.000277	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MAPK1—stomach cancer	3.12e-05	0.000273	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTT1—stomach cancer	3.09e-05	0.00027	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2A6—stomach cancer	3.05e-05	0.000267	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKR1C3—stomach cancer	2.97e-05	0.00026	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ENO1—stomach cancer	2.9e-05	0.000253	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GMPR2—stomach cancer	2.89e-05	0.000252	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CD44—stomach cancer	2.88e-05	0.000252	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.85e-05	0.000249	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA1—stomach cancer	2.84e-05	0.000249	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FBP1—stomach cancer	2.84e-05	0.000249	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NDUFA2—stomach cancer	2.84e-05	0.000249	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CKB—stomach cancer	2.84e-05	0.000249	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—stomach cancer	2.82e-05	0.000246	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HRAS—stomach cancer	2.81e-05	0.000246	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.79e-05	0.000244	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLIN2—stomach cancer	2.67e-05	0.000234	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—IDH3B—stomach cancer	2.64e-05	0.000231	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SUCLG1—stomach cancer	2.64e-05	0.000231	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA2—stomach cancer	2.6e-05	0.000227	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CD44—stomach cancer	2.57e-05	0.000225	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NT5E—stomach cancer	2.53e-05	0.000222	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PGAM1—stomach cancer	2.53e-05	0.000222	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—stomach cancer	2.51e-05	0.00022	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HRAS—stomach cancer	2.51e-05	0.000219	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.49e-05	0.000218	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NDUFS1—stomach cancer	2.45e-05	0.000214	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NDUFV1—stomach cancer	2.45e-05	0.000214	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPP2R1A—stomach cancer	2.45e-05	0.000214	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDH7A1—stomach cancer	2.42e-05	0.000211	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLCE1—stomach cancer	2.42e-05	0.000211	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—stomach cancer	2.4e-05	0.00021	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMOX1—stomach cancer	2.37e-05	0.000207	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—stomach cancer	2.34e-05	0.000205	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—UMPS—stomach cancer	2.32e-05	0.000203	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TYMS—stomach cancer	2.23e-05	0.000195	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—stomach cancer	2.21e-05	0.000193	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PGLS—stomach cancer	2.19e-05	0.000191	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BLVRB—stomach cancer	2.19e-05	0.000191	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPP2R1A—stomach cancer	2.18e-05	0.000191	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PDHA1—stomach cancer	2.15e-05	0.000188	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ECHS1—stomach cancer	2.15e-05	0.000188	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—stomach cancer	2.14e-05	0.000187	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMOX1—stomach cancer	2.11e-05	0.000185	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—stomach cancer	2.09e-05	0.000183	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.09e-05	0.000182	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ERCC2—stomach cancer	2.07e-05	0.000181	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TYMP—stomach cancer	2.03e-05	0.000177	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FADS1—stomach cancer	2.03e-05	0.000177	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TYMS—stomach cancer	1.99e-05	0.000174	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—stomach cancer	1.97e-05	0.000172	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—stomach cancer	1.95e-05	0.00017	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SREBF2—stomach cancer	1.9e-05	0.000166	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—RORA—stomach cancer	1.87e-05	0.000164	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FBP1—stomach cancer	1.86e-05	0.000163	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.86e-05	0.000163	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA1—stomach cancer	1.86e-05	0.000163	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CKB—stomach cancer	1.86e-05	0.000163	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ERCC2—stomach cancer	1.85e-05	0.000162	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAV1—stomach cancer	1.8e-05	0.000157	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOA1—stomach cancer	1.79e-05	0.000157	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDOB—stomach cancer	1.76e-05	0.000154	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLIN2—stomach cancer	1.75e-05	0.000153	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—stomach cancer	1.74e-05	0.000152	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.72e-05	0.00015	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA2—stomach cancer	1.7e-05	0.000149	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NT5E—stomach cancer	1.66e-05	0.000145	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PGAM1—stomach cancer	1.66e-05	0.000145	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALOX5—stomach cancer	1.63e-05	0.000143	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DPYD—stomach cancer	1.61e-05	0.00014	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAV1—stomach cancer	1.6e-05	0.00014	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOA1—stomach cancer	1.6e-05	0.00014	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—stomach cancer	1.58e-05	0.000138	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.58e-05	0.000138	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLCE1—stomach cancer	1.58e-05	0.000138	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.53e-05	0.000134	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—UMPS—stomach cancer	1.52e-05	0.000132	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—stomach cancer	1.42e-05	0.000124	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—stomach cancer	1.42e-05	0.000124	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—stomach cancer	1.41e-05	0.000123	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PDHA1—stomach cancer	1.41e-05	0.000123	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ECHS1—stomach cancer	1.41e-05	0.000123	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.4e-05	0.000123	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.37e-05	0.000119	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NOS3—stomach cancer	1.36e-05	0.000119	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ENO1—stomach cancer	1.33e-05	0.000116	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TYMP—stomach cancer	1.32e-05	0.000116	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FADS1—stomach cancer	1.32e-05	0.000116	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—stomach cancer	1.27e-05	0.000111	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—stomach cancer	1.24e-05	0.000109	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SREBF2—stomach cancer	1.24e-05	0.000108	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—RORA—stomach cancer	1.23e-05	0.000107	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NOS3—stomach cancer	1.21e-05	0.000106	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CD44—stomach cancer	1.18e-05	0.000103	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDOB—stomach cancer	1.15e-05	0.0001	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—stomach cancer	1.11e-05	9.7e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALOX5—stomach cancer	1.07e-05	9.33e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DPYD—stomach cancer	1.05e-05	9.18e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1e-05	8.78e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—stomach cancer	9.85e-06	8.61e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMOX1—stomach cancer	9.71e-06	8.49e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—stomach cancer	9.29e-06	8.12e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2A6—stomach cancer	9.18e-06	8.03e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TYMS—stomach cancer	9.16e-06	8e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—stomach cancer	9.05e-06	7.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKR1C3—stomach cancer	8.93e-06	7.81e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ENO1—stomach cancer	8.7e-06	7.61e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ERCC2—stomach cancer	8.51e-06	7.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—stomach cancer	8e-06	6.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CD44—stomach cancer	7.72e-06	6.75e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—stomach cancer	7.65e-06	6.69e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAV1—stomach cancer	7.38e-06	6.45e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOA1—stomach cancer	7.36e-06	6.43e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—stomach cancer	6.83e-06	5.97e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	6.56e-06	5.74e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—stomach cancer	6.49e-06	5.67e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—stomach cancer	6.44e-06	5.63e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMOX1—stomach cancer	6.35e-06	5.55e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TYMS—stomach cancer	5.99e-06	5.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—stomach cancer	5.92e-06	5.17e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—stomach cancer	5.83e-06	5.1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NOS3—stomach cancer	5.58e-06	4.88e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ERCC2—stomach cancer	5.56e-06	4.86e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—stomach cancer	5.23e-06	4.57e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—stomach cancer	5.1e-06	4.46e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAV1—stomach cancer	4.82e-06	4.22e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOA1—stomach cancer	4.81e-06	4.21e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—stomach cancer	4.24e-06	3.71e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—stomach cancer	3.81e-06	3.33e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NOS3—stomach cancer	3.65e-06	3.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—stomach cancer	3.34e-06	2.92e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—stomach cancer	3.14e-06	2.74e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.05e-06	1.79e-05	CbGpPWpGaD
